Vitamin E (α-tocopherol) in the treatment of tardive dyskinesia: A statistical meta-analysis

Annals of Clinical Psychiatry

Volumn 10, Issue 3, 1998, Pages 101-105

  Barak, Yoram ^a,b,d   Swartz, Marnina ^a,b   Shamir, Eyal ^a,b   Stein, Daniel ^a,b   Weizman, Abraham ^b,c  

^a ABARBANEL MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

^d Psychogeriatric Department   (Israel)

Author keywords

AIMS; Efficacy; Meta analysis; Tardive dyskinesia; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TARDIVE DYSKINESIA; TREATMENT OUTCOME; VARIANCE;

ADULT; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN E;

EID: 0031788006     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022349920283     Document Type: Article

References (43)

1. Gerlach J, Casey D: Drug treatment of schizophrenia: Myths and realities. Curr Opin Psychiatry 1994; 7:65-70
2. 2-dopamine receptor occupancy in relation to antipsychotic effects: A double-blind PET study of schizophrenic patients. Biol Psychiatry 1993; 33:227-235
3. Klawans HL: The pharmacology of tardive dyskinesia. Am J Psychiatry 173; 130:82-86
4. Feltner ED, Hertzman M: Progress in the treatment of tardive dyskinesia: Theory and practice. Hosp Commun Psychiatry 1993; 44:25-34
5. Jeste DV, Wyatt RJ: Understanding and Treating Tardive Dyskinesia. New York: Guilford Press; 1982
6. Woerner MG, Kane JM, Lieberman JA: The prevalence of tardive dyskinesia. J Clin Psychopharmacol 1991; 11:34-42
7. Khot V, Wyatt RJ: Not all that moves is tardive dyskinesia. Am J Psychiatry 1991; 148:661-666
8. Youssef HA, Waddington JL: Morbidity and mortality in tardive dyskinesia: Association in chronic schizophrenia. Acta Psychiatr Scand 1987; 85:74-77
9. APA: Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC; APA, 1992
10. Hay DP, Hay L, Blackweek B, Spiro HR: ECT and tardive dyskinesia. J Geriatr Psychiatry Neurol 1990; 3:106-109
11. Boodho JA, Sandier M: Anticholinergic antiparkinsonian drugs in psychiatry. Br J Hosp Med 1991; 46:167-169
12. Mouret J, Khomais M, Lemoine P, Sebert P: Low doses of insulin as a treatment of tardive dyskinesia: Conjuncture or conjecture? Eur Neurol 1991; 31:199-203
13. Fudge RC, Thailer SA, Alpert M, Intruder J, Sison CE: The effect of electromyographic feedback training on suppression of the oral-lingual movements associated with tardive dyskinesia. Biofeed Self Regul 1991; 16:117-129
14. Thaker GK, Nguyen JA, Strauss ME, Jacobson R, Kaup BA, Tamminga CA: Clonazepam treatment of tardive dyskinesia: A practical GABA mimetic strategy. Am J Psychiatry 1990; 147:445-451
15. Mendis L: Levodopa rice eating and on-off phenomenon. Ceylon Med J 1993; 38:198-199
16. Wittenberg N, Stein D, Barak Y, Achiron A: Clozapine and tardive dyskinesia: Analysis of clinical trails. Pathophysiology 1996; 3:241-245
17. Geleberg A, Dorrer DJ, Wojcik JD, Falk WE, Brotman AW, Leahy L: A crossover study of lecithin treatment of tardive dyskinesia. J Clin Psychiatry 1990; 51:149-153
18. Goff DC, Renshaw PF, Sarid-Degal O, Dreyfuss DA, Amico ET, Crinalo DA: A placebo-controlled trial of selegiline (1-deprenyl) in the treatment of tardive dyskinesia Biol Psychiatry 1993; 33:700-706
19. Tamminga CA, Thanker GA, Moran M, Kaigi T, Gao XM: Clozapine in tardive dyskinesia: Observations from human and animal model studies. J Clin Psychiatry 1994; 55 (Suppl B):102-106
20. Halliwell B: Oxidants and the central nervous system: Some fundamental questions. Acta Neurol Scand 1989; 126:23-33
21. Cadenos E, Ginsberg M: Evaluation of alpha-tocopherol antioxidant activity. Biochem J 1986; 223:755-759
22. Oske FA: Vitamin E, a radical defense. N Eng J Med 1980; 303:454-455
23. Bieri JG, Corash L, Hubbard VS: Medical uses of vitamin E. N Eng J Med 1983; 308:1063-1071
24. Bischot L, Van-den-Brink G, Porsius AJ: Vitamin E in extrapyramidal disorders. Pharm World Sci 1993; 15(4): 146-150
25. Cohen G: Oxyradical toxicity in catecholamine neurons. Neurotoxicology 1984; 5:77-82
26. Machlin LJ: Use and safety of elevated dosages of vitamin E in adults. Int J Vitam Nutr Res 1989; 30:56-68
27. Lohr JB, Cadet JL, Lohr MA, Jeste DV, Wyatt RJ: Alpha-tocopherol in tardive dyskinesia Lancet 1987; 1 (8538):913-914
28. Glass GV: Primary secondary and metanalysis of research. Educ Res 1976; 5:3-8
29. Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction. An overview of randomized trials. Prog Cardiovasc Dis 1985; 27:335-371
30. Emilien G, Maloteaux JM, Seghers A, Charles G: Lithium compared to valproic acid and carbamazepine in the treatment of mania: A statistical meta-analysis. Eur Neuropsychopharm 1996; 6:245-252
31. Dabiri LM, Pasta D, Darby JK, Mosbacher D: Effectiveness of vitamin E for treatment of long term tardive dyskinesia. Am J Psychiatry 1994; 151:925-926
32. Adler LA, Peselow E, Duncan E, Roshenthal M, Angrist B: Vitamin E in tardive dyskinesia: Time course of effect after placebo substitution. Psychopharmacol Bull 1993; 29(3):371-374
33. Adler L, Peselous E, Rotrosen J, Duncan E, Lee M, Rosental M, Angrist B: Vitamin treatment of tardive dyskinesia. Am J Psychiatry 1993; 150:1405-1407
34. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ: Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 1992; 149:773-777
35. Elkashef AM, Ruskin PE, Bacher N, Barrett D: Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry 1990; 147:505-506
36. Lam LCW, Chin HFK, Hung SF: Vitamin E in the treatment of tardive dyskinesia: A replication study. J Nerv Ment Dis 1994; 182(2):113-114
37. Spivak B, Schwartz B, Radwan M, Weizman A: Tocopherol treatment for tardive dyskinesia. J Nerv Ment Dis 1992; 180(3):400-401
38. Shriqui C, Bradwejn J, Annable L, Jones BD: Vitamin E in the treatment of tardive dyskinesia: A double-blind placebo-controlled study. Am J Psychiatry 1992; 149:391-393
39. Langharne PM, Rangarajan N, Reynolds CP: Tardive dyskinesia, lipid peroxidation and sustained amelioration with vitamin E treatment. Int Clin Psychopharmacol 1993; 8:151-153
40. Akhtar S, Jajor TR, Kumar S: Vitamin E in the treatment of tardive dyskinesia. J Postgrad Med 1993; 39(3):124-126
41. Lohr JB, Caligiuri MP: A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 1996; 57:167-173
42. Soares K, McGrath J, Adams C: Evidence and tardive dyskinesia. Lancet 1996; 347:1696-1697.
43. LeLorier J, Gregorie G, Benhaddad A, Lapierre J, Derderian F: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Eng J Med 1997; 337:536-542